Pfizer planning layoffs, targeting US sales reps

NEW YORK — Drug maker Pfizer Inc. is starting another round of layoffs, targeting US sales representatives who promote Pfizer primary care medicines to doctors.

The New York Viagra maker has not detailed how many salespeople it employs, how many will leave, or when that will happen. Individual salespeople haven’t been notified whether they’ll be furloughed.

A Pfizer spokesman confirms changes are coming but says details about the sales force are proprietary.


In a statement, the world’s biggest drug maker says it continually evaluates how to be more efficient and best allocate money and staff to serve customers.

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

Generic competition to popular drugs such as Pfizer’s cholesterol blockbuster Lipitor means they’re not promoted anymore.

But reps are needed to promote a big anticlotting drug awaiting approval and current big sellers like pain treatment Lyrica.